235 related articles for article (PubMed ID: 10821704)
1. Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
Bavetsias V; Marriott JH; Melin C; Kimbell R; Matusiak ZS; Boyle FT; Jackman AL
J Med Chem; 2000 May; 43(10):1910-26. PubMed ID: 10821704
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of thymidylate synthase by two series of nonclassical quinazolines.
McNamara DJ; Berman EM; Fry DW; Werbel LM
J Med Chem; 1990 Jul; 33(7):2045-51. PubMed ID: 2362285
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent non-polyglutamatable quinazoline antifolate thymidylate synthase inhibitors.
Marsham PR; Wardleworth JM; Boyle FT; Hennequin LF; Kimbell R; Brown M; Jackman AL
J Med Chem; 1999 Sep; 42(19):3809-20. PubMed ID: 10508430
[TBL] [Abstract][Full Text] [Related]
5. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
6. Folate-based thymidylate synthase inhibitors as anticancer drugs.
Jackman AL; Calvert AH
Ann Oncol; 1995 Nov; 6(9):871-81. PubMed ID: 8624289
[TBL] [Abstract][Full Text] [Related]
7. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
Jackman AL; Kelland LR; Kimbell R; Brown M; Gibson W; Aherne GW; Hardcastle A; Boyle FT
Br J Cancer; 1995 May; 71(5):914-24. PubMed ID: 7537518
[TBL] [Abstract][Full Text] [Related]
9. Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agents.
Bavetsias V; Jackman AL
Curr Med Chem; 1998 Aug; 5(4):265-88. PubMed ID: 9668195
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.
Hughes LR; Jackman AL; Oldfield J; Smith RC; Burrows KD; Marsham PR; Bishop JA; Jones TR; O'Connor BM; Calvert AH
J Med Chem; 1990 Nov; 33(11):3060-7. PubMed ID: 2231606
[TBL] [Abstract][Full Text] [Related]
12. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
[TBL] [Abstract][Full Text] [Related]
14. Quinazoline antifolate thymidylate synthase inhibitors: difluoro-substituted benzene ring analogues.
Thornton TJ; Jackman AL; Marsham PR; O'Connor BM; Bishop JA; Calvert AH
J Med Chem; 1992 Jun; 35(12):2321-7. PubMed ID: 1613755
[TBL] [Abstract][Full Text] [Related]
15. Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series.
Marsham PR; Jackman AL; Oldfield J; Hughes LR; Thornton TJ; Bisset GM; O'Connor BM; Bishop JA; Calvert AH
J Med Chem; 1990 Nov; 33(11):3072-8. PubMed ID: 2231608
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications.
Marsham PR; Hughes LR; Jackman AL; Hayter AJ; Oldfield J; Wardleworth JM; Bishop JA; O'Connor BM; Calvert AH
J Med Chem; 1991 May; 34(5):1594-605. PubMed ID: 2033585
[TBL] [Abstract][Full Text] [Related]
17. Gamma-linked dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8- dideazafolate as antitumour agents.
Jackman AL; Bisset GM; Jodrell DI; Gibson W; Kimbell R; Bavetsias V; Calvert AH; Harrap KR; Stephens TC; Smith MN
Adv Exp Med Biol; 1993; 338():579-84. PubMed ID: 8304184
[TBL] [Abstract][Full Text] [Related]
18. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
20. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
